VOLORIDGE INVESTMENT MANAGEMENT, LLC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1556921
JUPITER, FL
Position in NTLA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,962,743
+$14,302,878 QoQ
Shares Held
2,066,356
+28.2% QoQ
Ownership
1.47%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#18
of 330 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOLORIDGE INVESTMENT MANAGEMENT, LLC holds $412,638,399 across 27 Biotechnology names. NTLA ranks #4 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
163,963 | $102,237,489 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
655,454 | $51,970,947 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,241,556 | $41,455,554 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
This page
|
2,066,356 | $34,962,743 | |
| 5 | EXEL |
Exelixis, Inc.
|
578,873 | $31,496,479 | |
| 6 | BNTX |
BioNTech SE
|
243,422 | $22,650,417 | |
| 7 | ABSI |
Absci Corp
|
1,602,916 | $18,577,796 | |
| 8 | ARGX |
Argenx SE
|
18,797 | $17,439,292 |
All Filings in NTLA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,962,743 | 2,066,356 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $20,659,865 | 1,611,534 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,619,675 | 1,737,450 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $27,808,240 | 1,610,205 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,569,334 | 1,553,234 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,776,015 | 1,515,614 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $17,804,750 | 1,526,994 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,601,843 | 467,243 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,125,786 | 452,448 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,884,590 | 795,514 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,013,975 | 33,256 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $2,954,225 | 72,443 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,109,771 | 83,439 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $775,883 | 22,238 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $5,143,857 | 99,379 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,051,146 | 69,508 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,969,346 | 50,485 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $30,589,017 | 228,021 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $16,774,361 | 103,603 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $264,819 | 4,868 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $505,747 | 25,440 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||